Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Assess which Dividend Aristocrats ETF offers the lowest expenses while maintaining solid diversification and dividend potential for your portfolio.
27,511 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
A podcast recap attributes a Bezos stance to exempting the bottom half from federal income taxes, highlighting a broa...
Jim Cramer cautions that AI stock surges can reverse sharply if earnings fail to accelerate, a warning that comes as ...
Iran faces a sharp economic decline after renewed conflict, with staple prices surging and millions at risk of povert...
A 78-year-old retiree weighs safe, steady income options for a disabled heir with $111K in savings, as rates rise and...
Reddit reveals a bold plan to reach one billion users, signaling a major shift from niche message boards to a mainstr...
A large insider sale often sparks questions about a company’s future. This article breaks down what the move means, h...
Artificial intelligence is remaking markets. This guide explains why leaders Nvidia, Palantir, and Meta matter for in...
SpaceX, Rocket Lab, and AST SpaceMobile retreat as a China rocket milestone and an oil price spike pressure space-sto...
A rising domestic memory player is lining up a major public listing to challenge established DRAM leaders. Investors ...
Backpack is launching a year-long staking program that could convert a portion of its tokens into a 20% equity stake ...
The Old-Age and Survivors Insurance fund faces insolvency by 2032, threatening automatic benefit adjustments unless l...